Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: N/A
- Sub-Industry: N/A
- Symbol: FRA:BAYN
- CUSIP: N/A
- Web: N/A
- 50 Day Moving Avg: €110.07
- 200 Day Moving Avg: €110.69
- Trailing P/E Ratio: 18.64
- P/E Growth: 0.00
Frequently Asked Questions for Bayer AG (FRA:BAYN)
What is Bayer AG's stock symbol?
Bayer AG trades on the FRA under the ticker symbol "BAYN."
Where is Bayer AG's stock going? Where will Bayer AG's stock price be in 2017?
22 equities research analysts have issued twelve-month price objectives for Bayer AG's stock. Their predictions range from €102.00 to €150.00. On average, they anticipate Bayer AG's stock price to reach €120.05 in the next twelve months. View Analyst Ratings for Bayer AG.
Who are some of Bayer AG's key competitors?
MarketBeat Community Rating for Bayer AG (FRA BAYN)MarketBeat's community ratings are surveys of what our community members think about Bayer AG and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Some companies that are related to Bayer AG include Partnership Assurance Group PLC (PA), Merck & Co. (MRK), AstraZeneca plc (AZN), GlaxoSmithKline plc (GSK), AstraZeneca plc (AZN), Shire PLC (SHP), Hospira (HSP), Smith & Nephew plc (SN), Omnicare (OCR), Alnylam Pharmaceuticals (ALNY), Valeant Pharmaceuticals Intl (VRX), ConvaTec Group PLC (CTEC), Mediclinic International PLC (MDC), Health Net (HNT), Patheon NV (PTHN), NMC Health PLC (NMC), Catalent (CTLT) and Cotiviti Holdings (COTV).
Consensus Ratings for Bayer AG (FRA:BAYN) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||9 Hold Ratings, 13 Buy Ratings|
|Consensus Rating:||Buy (Score: 2.59)|
|Consensus Price Target: ||€120.05|
Analysts' Ratings History for Bayer AG (FRA:BAYN)
(Data available from 8/17/2015 forward)
|8/11/2017||Deutsche Bank AG||Set Price Target||Buy||€124.00|
|8/8/2017||DZ Bank AG||Reiterated Rating||Neutral|
|8/8/2017||Goldman Sachs Group, Inc. (The)||Set Price Target||Buy||€125.00|
|8/7/2017||J P Morgan Chase & Co||Set Price Target||Buy||€125.00|
|7/28/2017||Nord/LB||Set Price Target||Neutral||€106.00|
|7/27/2017||S&P Global||Set Price Target||Buy||€120.00|
|7/27/2017||Kepler Capital Markets||Set Price Target||Neutral||€102.00|
|7/27/2017||Baader Bank||Set Price Target||Neutral||€120.00|
|7/27/2017||Independent Research GmbH||Set Price Target||Neutral||€120.00|
|7/27/2017||Sanford C. Bernstein||Set Price Target||Buy||€128.00|
|7/27/2017||equinet AG||Set Price Target||Buy||€118.00|
|7/27/2017||Commerzbank Ag||Set Price Target||Buy||€126.00|
|7/24/2017||Citigroup Inc.||Set Price Target||Buy||€128.00|
|7/10/2017||Jefferies Group LLC||Set Price Target||Buy||€150.00|
|7/4/2017||Societe Generale||Set Price Target||Neutral||€117.00|
|7/3/2017||BNP Paribas||Set Price Target||Neutral||€103.00|
|7/3/2017||Berenberg Bank||Set Price Target||Neutral||€121.00|
|6/12/2017||Bank of America Corporation||Set Price Target||Buy||€140.00|
|4/28/2017||HSBC Holdings plc||Set Price Target||Neutral||€107.00|
|4/27/2017||Warburg Research||Set Price Target||Buy||€118.00|
|11/9/2016||Bankhaus Lampe||Set Price Target||Buy||€103.00|
|10/26/2016||S&P Global Inc.||Set Price Target||Buy||€120.00|
|4/27/2016||Morgan Stanley||Set Price Target||Sell||€105.00|
|4/27/2016||Barclays PLC||Set Price Target||Neutral||€108.00|
|4/27/2016||Credit Suisse Group||Set Price Target||Neutral||€117.00|
|10/29/2015||S&P Equity Research||Set Price Target||Buy||€147.00|
Earnings History for Bayer AG (FRA:BAYN)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Bayer AG (FRA:BAYN)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Bayer AG (FRA:BAYN)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Bayer AG (FRA:BAYN)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Bayer AG (FRA:BAYN)
Latest Headlines for Bayer AG (FRA:BAYN)